Latest Morning Briefing Stories

KHN’s ‘What the Health?’: The Return of the Public Option

KFF Health News Original

Lawmakers are working on fleshing out the concept of a “public option,” a government-run or heavily regulated insurance plan that would compete with private insurance. But the details are complicated, both substantively and politically. Meanwhile, bioethicists are debating whether the U.S. should be vaccinating low-risk adolescents against covid-19 while high-risk adults in other countries are still waiting. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

No-Cancel Culture: How Telehealth Is Making It Easier to Keep That Therapy Session

KFF Health News Original

No-shows for behavioral health appointments have been a long-standing problem, with up to 60% skipped. Now telehealth, fueled by the pandemic, makes it easier for people dealing with depression and other mental health issues to make it to their appointments at a time when such care is in high demand. But teletherapy creates other challenges.

KHN’s ‘What the Health?’: Drug Price Effort Hits a Snag

KFF Health News Original

Democratic leaders in Congress have vowed to pass legislation to address high prescription drug prices this year, but some moderates in their own party appear to be balking. Meanwhile, younger teens are now eligible for a covid-19 vaccine and the Biden administration reinstated anti-discrimination policy for LGBTQ people in health care. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.